Skip to main content
Oramed Pharmaceuticals Inc. logo

Oramed Pharmaceuticals Inc. — Investor Relations & Filings

Ticker · ORMP ISIN · US68403P2039 LEI · 5299006K52ZIIGQJ6R84 TA Manufacturing
Open in API
Filings indexed 1,576 across all filing types
Latest filing 2024-03-19 Capital/Financing Update
Country US United States of America
Listing TA ORMP

About Oramed Pharmaceuticals Inc.

https://www.oramed.com

Oramed Pharmaceuticals Inc. is a clinical-stage company focused on developing oral drug delivery systems for medications that are typically administered via injection. The company's core technology is its proprietary Protein Oral Delivery (POD™) platform, which is designed to protect therapeutic proteins from enzymatic degradation in the gastrointestinal tract and enhance their absorption into the bloodstream. Oramed's lead product candidate is an oral insulin capsule (ORMD-0801) for the treatment of diabetes. The company's pipeline also includes an oral GLP-1 analog capsule (ORMD-0901) for type 2 diabetes. Oramed aims to improve patient compliance, comfort, and therapeutic outcomes by converting injectable treatments into oral formulations.

Recent filings

Filing Released Lang Actions
Update on the receipt of payments for the Scilex transaction
Capital/Financing Update Classification · 99% confidence The document explicitly states it is a "FORM 8-K" and a "CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934". Form 8-K filings are used to announce major events that shareholders should know about between quarterly (10-Q) and annual (10-K) reports. None of the provided specific codes (like 10-K, ER, DIV, etc.) perfectly match the general nature of a Form 8-K reporting 'Other Events' (Item 8.01) regarding debt payments and previous agreements. Since Form 8-K is a general current report for material events, and there is no specific 'Form 8-K' code, the most appropriate fallback category for a general, material regulatory filing that doesn't fit the other specific definitions is 'Regulatory Filings' (RNS). The document is substantial and contains detailed information, so it is not an RPA.
2024-03-19 English
Update on the receipt of payments for the Scilex transaction
Regulatory Filings Classification · 95% confidence The document explicitly mentions it is an 'Other Report or Announcement' filed under 'Regulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000'. Crucially, it states: 'Attached hereto is a report on *Form 8-K*'. A Form 8-K is an SEC filing used to announce major events that shareholders should know about. Since this document is an announcement *about* an attached Form 8-K (which is a specific type of immediate report not covered by the primary codes like 10-K or IR), and given its short length (1861 chars) and the nature of announcing the availability of another report, it best fits the general 'Regulatory Filings' category (RNS) as a fallback for miscellaneous, immediate, non-standard regulatory announcements, or potentially as a general announcement (RPA) if the focus is purely on the publication act. However, since it is a specific regulatory filing (8-K) being announced, RNS is the most appropriate general regulatory fallback category when a more specific code like ER, CAP, or DIV is not applicable. It is not the full 10-K, IR, or a specific management/dividend announcement.
2024-03-19 English
CURRENT REPORT
Regulatory Filings
2024-03-19 English
Appointed Mr. Yehuda Reznick to serve as a director
Board/Management Information Classification · 98% confidence The document is explicitly titled "FORM 8-K" and is filed pursuant to the Securities Exchange Act of 1934. Form 8-K is used to report major events that shareholders should know about. The key item reported under "Item 5.02" is the appointment of a new director (Mr. Yehuda Reznick) and his committee assignments. This type of announcement—a change in senior management or board composition—directly corresponds to the definition of Board/Management Information (MANG). While Form 8-K is a general regulatory filing, the specific content points strongly to MANG, which is a more precise classification than the general 'RNS' fallback.
2024-03-18 English
Appointed Mr. Yehuda Reznick to serve as a director
Report Publication Announcement Classification · 98% confidence The document explicitly states it is an 'Other Report or Announcement' filed under 'Regulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000'. Crucially, it states: 'Attached hereto is a report on *Form 8-K*'. A Form 8-K is an SEC filing used to announce major events that shareholders should know about. Since this document is an announcement *about* an attached Form 8-K (which is a type of immediate report), and given its short length (1864 chars) and the nature of announcing an attached filing, it fits the criteria for a Report Publication Announcement (RPA) or potentially a general Regulatory Filing (RNS). Since RPA specifically covers the announcement of report publication, it is the most precise fit over the general RNS category, as it is clearly announcing the release of a specific regulatory form (8-K).
2024-03-18 English
entered into ATM Agreemen with Agents having maximum aggregate offering price up to 75,000,000$
Regulatory Filings Classification · 100% confidence The document explicitly states it is a "FORM 8-K" and a "CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934." The content details the entry into a material definitive agreement (Item 1.01) regarding an 'at the market offering' for the sale of common stock, and the termination of a previous agreement (Item 1.02). Form 8-K filings report significant, unscheduled material events. None of the provided specific codes (10-K, IR, ER, DIV, etc.) fit the nature of a Form 8-K reporting material corporate events like financing agreements. Since Form 8-K is a general current report mandated by the SEC for material events not covered by other specific periodic reports, and it doesn't fit the specialized categories like AGM-R, DEF 14A, or CT, the most appropriate fallback category is 'Regulatory Filings' (RNS), which serves as the general category for miscellaneous SEC filings that are not the primary defined reports.
2024-03-18 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.